# Increlex

NDC: 15054-1040
Generic name: mecasermin
Labeler / Manufacturer: Ipsen Biopharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20060103
Marketing ended: 20271231
FDA application: BLA021839

## Active ingredients

- MECASERMIN: 40 mg/4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"15054-1040"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=15054-1040
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a8b27a1b-a611-4f91-ad22-76d4b390c3ae